Pathologic correlation of 89Zr-Df-IAB2M antiprostate-specific membrane antigen (PSMA) minibody in patients with metastatic prostate cancer.

被引：0
|
作者：
Morris, Michael J.
Solomon, Stephen Barnett
Durack, Jeremy C.
O'Donoghue, Joseph A.
Lyashchenko, Serge K.
Ruan Shutian
Carrasquillo, Jorge A.
Lewis, Jason Stuart
Martinez, Danny F.
Parada, Nicole A.
Keppler, Jennifer
Wu, Anna
Reuter, Victor E.
Weber, Wolfgang
Scher, Howard I.
Larson, Steven M.
Pandit-Taskar, Neeta
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Intervent Radiol & Image Guided Therapies, New York, NY 10021 USA
[3] ImaginAb Inc, Inglewood, CA USA
[4] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Crump Inst Mol Imaging, Los Angeles, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 07期
关键词：
D O I：
10.1200/jco.2015.33.7_suppl.220
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
220
引用
收藏
页数：1
相关论文
共 50 条
  • [1] First in Human 89Zr-Df-IAB2M antiprostate specific membrane antigen (PSMA) minibody in patients with metastatic prostate cancer.
    Pandit-Taskar, Neeta
    O'Donoghue, Joseph
    Martinez, Danny
    Lyashchenko, Serge
    Carrasquillo, Jorge
    Durack, Jeremy
    Keppler, Jennifer
    Scher, Howard
    Larson, Steven
    Morris, Michael
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [2] Potential use of prostate specific membrane antigen (PSMA) for detecting the tumor neovasculature of brain tumors by PET imaging with 89Zr-Df-IAB2M anti-PSMA minibody
    Matsuda, Masahide
    Ishikawa, Eiichi
    Yamamoto, Tetsuya
    Hatano, Kentaro
    Joraku, Akira
    Iizumi, Yuichi
    Masuda, Yosuke
    Nishiyama, Hiroyuki
    Matsumura, Akira
    JOURNAL OF NEURO-ONCOLOGY, 2018, 138 (03) : 581 - 589
  • [3] Potential use of prostate specific membrane antigen (PSMA) for detecting the tumor neovasculature of brain tumors by PET imaging with 89Zr-Df-IAB2M anti-PSMA minibody
    Masahide Matsuda
    Eiichi Ishikawa
    Tetsuya Yamamoto
    Kentaro Hatano
    Akira Joraku
    Yuichi Iizumi
    Yosuke Masuda
    Hiroyuki Nishiyama
    Akira Matsumura
    Journal of Neuro-Oncology, 2018, 138 : 581 - 589
  • [4] A phase I/IIa trial of prostate specific membrane antigen (PSMA) positron emission tomography (PET) imaging with 89Zr-Df-IAB2M in metastatic prostate cancer (PCa)
    Morris, Michael J.
    Martinez, Danny Francisco
    Durack, Jeremy C.
    Slovin, Susan F.
    Danila, Daniel Costin
    O'Donoghue, Joseph A.
    Parada, Nicole Andrea
    Lyashchenko, Serge K.
    Carrasquillo, Jorge A.
    Ruan, Shutian
    Lewis, Jason Stuart
    Keppler, Jennifer
    Wu, Anna M.
    Reuter, Victor E.
    Weber, Wolfgang
    Scher, Howard I.
    Larson, Steven M.
    Pandit-Taskar, Neeta
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [5] First-in-Human Imaging with 89Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake
    Pandit-Taskar, Neeta
    O'Donoghue, Joseph A.
    Ruan, Shutian
    Lyashchenko, Serge K.
    Carrasquillo, Jorge A.
    Heller, Glenn
    Martinez, Danny F.
    Cheal, Sarah M.
    Lewis, Jason S.
    Fleisher, Martin
    Keppler, Jennifer S.
    Reiter, Robert E.
    Wu, Anna M.
    Weber, Wolfgang A.
    Scher, Howard I.
    Larson, Steven M.
    Morris, Michael J.
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (12) : 1858 - 1864
  • [6] 89Zr-df-IAB2M for PET/CT imaging of prostate cancer
    Batra, J. S.
    Jhanwar, Y. S.
    Vallabhajosula, S.
    Niaz, M. J.
    Flynn, T.
    Tagawa, S. T.
    Bander, N. H.
    Scherr, D. S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S295 - S295
  • [7] 89ZR-DF-IAB2M AND 68GA-PSMA-11 IMAGING IN LOCALIZED PRE-PROSTATECTOMY PROSTATE CANCER PATIENTS
    Niaz, Muhammad Junaid
    Jhanwar, Yuliya
    Flynn, Thomas
    Vallabhajosula, Shankar
    Batra, Jaspreet
    Tagawa, Scott
    Khani, Francesca
    Robinson, Brian
    Bander, Neil
    Scherr, Douglas
    JOURNAL OF UROLOGY, 2019, 201 (04): : E1161 - E1162
  • [8] Pilot study of the diagnostic utility of 89Zr-df-IAB2M and 68Ga-PSMA-11 PET imaging and multiparametric MRI in localized prostate cancer
    Vlachostergios, Panagiotis J.
    Niaz, Muhammad J.
    Thomas, Charlene
    Christos, Paul J.
    Osborne, Joseph R.
    Margolis, Daniel J. A.
    Khani, Francesca
    Bander, Neil H.
    Scherr, Douglas S.
    Tagawa, Scott T.
    PROSTATE, 2022, 82 (04): : 483 - 492
  • [9] [89Zr]Zr-Df-IAB22M2C in metastatic cancer
    Geraldes, Flavia Oliveira
    LANCET ONCOLOGY, 2021, 22 (12): : 1655 - 1655
  • [10] Tumor-directed PET imaging of metastases in metastatic castration-resistant prostate cancer (mCRPC) using Zr-89 labeled antiprostate-specific membrane antigen (PSMA) antibody J591.
    Feldman, Jarett L.
    Morris, Michael J.
    Martinez, Danny F.
    Tagawa, Scott T.
    Nanus, David M.
    Solomon, Stephen Barnett
    Carrasquillo, Jorge A.
    Reuter, Victor E.
    Lewis, Jason Stuart
    Donoghue, Joseph A. O'
    Slovin, Susan F.
    Rathkopf, Dana E.
    Gonen, Mithat
    Beylergil, Volkan
    Durack, Jeremy C.
    Cheal, Sarah M.
    Bander, Neil Harrison
    Scher, Howard I.
    Larson, Steven M.
    Pandit-Taskar, Neeta
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345